Steven F. Bellon - May 25, 2022 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Scientific Officer
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
Stock symbol
FHTX
Transactions as of
May 25, 2022
Transactions value $
$14,320
Form type
4
Date filed
5/27/2022, 04:10 PM
Previous filing
Jan 28, 2022
Next filing
Aug 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FHTX Common Stock Options Exercise $493 +675 +0.58% $0.73* 116K May 25, 2022 Direct
transaction FHTX Common Stock Options Exercise $13.8K +3.72K +3.19% $3.72 120K May 25, 2022 Direct
holding FHTX Common Stock 50K May 25, 2022 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Options (Right to buy) Options Exercise $0 -675 -100% $0.00* 0 May 25, 2022 Common Stock 675 $0.73 Direct F2
transaction FHTX Stock Options (Right to buy) Options Exercise $0 -3.72K -40.01% $0.00 5.57K May 25, 2022 Common Stock 3.72K $3.72 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by the Steven F. Bellon 2021 Irrevocable Trust dated December 3, 2021, of which the Reporting Person's children are the trustees.
F2 The option vested at a rate of 6.25% of the underlying shares beginning on April 1, 2018 and thereafter on the first day of each calendar quarter until the option was fully vested.
F3 The option vested as to 25% of the underlying shares of common stock on January 30, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.